Now showing items 1-8 of 8
Lung cancer in Agder counties in Southern Norway - results from a three year unselected inclusion of patients with newly diagnosed lung cancer
(The University of Bergen, 2009-11-10)
Studies on homocysteine-lowering B-vitamin therapy in patients with coronary artery diseas : sub-studies from the Western Norway B-vitamin intervention trial (WENBIT)
(The University of Bergen, 2008-06-06)
Background: A high plasma level of total homocysteine (tHcy) is a risk factor for cardiovascular disease, and is related to important components of atherosclerosis such as inflammation and endothelial dysfunction. Objectives: ...
Early outcome and restenosis after coronary stenting : intervention with stent-coatings, antioxidants and radiation
(The University of Bergen, 2007-03-16)
Antimicrobial resistance in bacterial infections in urban and rural Tanzania
(The University of Bergen, 2007-05-16)
Infectious diseases cause one in every six deaths worldwide. Antimicrobial drugs have helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria ...
The effects of smoking cessation intervention in patients with coronary heart disease : a randomised, controlled trial
(The University of Bergen, 2007-02-09)
Background: Smoking cessation is the most important action to reduce mortality after a coronary event. Largely, it has previously been unknown whether a smoking cessation program applicable in an ordinary clinical setting ...
p53 protein biosignatures in acute myeloid leukemia
(The University of Bergen, 2006-03-10)
p53 is a tumor suppressor protein often regarded as the guardian of the genome. It is a highly connected protein involved in many signaling processes in the cell. The inactivation of p53 through genetic mutations in TP53 ...
Small-Diameter Nerve Fiber Neuropathy in Patients with Systemic Autoimmune Diseases
(The University of Bergen, 2006-10-13)